Combidex Broad Indication Appropriateness To Be Topic For Advisory Committee
This article was originally published in The Pink Sheet Daily
FDA questions whether Combidex can be used to detect metastatic lymph nodes in a broad range of cancer types. The agency will also ask the committee to discuss the product’s risk of anaphylactic/anaphylactoid reactions and recommend strategies to mitigate the risk.
You may also be interested in...
Advanced Magnetics' Combidex NDA has a user fee goal date of March 30, 2005
Amended application includes 50 mg and 100 mg dosage forms, which are used in multiple myeloma.
Sepracor's television ads for its sleep aid Lunesta create brand recognition better than other new prescription drug direct-to-consumer ads, according to an analysis performed by IAG Research